ABHD14A Activators comprise a sophisticated category of chemical compounds specifically designed to enhance the enzymatic activity of ABHD14A, a member of the α/β-hydrolase domain containing family of enzymes. ABHD14A is recognized for its role in various cellular processes, including lipid metabolism and the modulation of specific signaling pathways. The precise biological function of ABHD14A, however, remains an area of active research, with emerging studies suggesting its involvement in the hydrolysis of specific substrates, potentially influencing cellular homeostasis and signaling. Activators of ABHD14A are synthesized through complex chemical processes, aimed at increasing the enzyme's catalytic efficiency towards its natural or synthetic substrates. These compounds are meticulously engineered to interact with ABHD14A, potentially altering its conformation to enhance substrate accessibility and catalysis. The design of ABHD14A Activators is grounded in a deep understanding of the enzyme's structure, catalytic mechanism, and substrate specificity, employing techniques such as molecular docking and structure-based drug design to identify and optimize potential activator molecules.
The research surrounding ABHD14A Activators involves an interdisciplinary approach, utilizing advanced methodologies from enzymology, structural biology, and medicinal chemistry. Scientists employ techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy to elucidate the three-dimensional structure of ABHD14A, identifying key active site residues and potential allosteric sites for activator binding. Kinetic assays and activity-based protein profiling are used to assess the impact of activators on ABHD14A's enzymatic activity, providing insights into the mechanisms by which these compounds enhance enzyme function. Computational studies, including molecular dynamics simulations and virtual screening, play a pivotal role in predicting the interaction dynamics between ABHD14A and potential activators, guiding the rational design and optimization of these compounds. Through this comprehensive research framework, the study of ABHD14A Activators aims to contribute significantly to our understanding of the enzyme's role in cellular metabolism and signaling, advancing the field of enzyme regulation and molecular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which may influence the expression of genes involved in lipid metabolism, possibly including ABHD14A. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPAR-gamma agonist, rosiglitazone regulates genes involved in lipid metabolism, which could hypothetically affect ABHD14A expression. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Similar to rosiglitazone, pioglitazone activates PPAR-gamma and may indirectly affect the expression of ABHD14A through lipid metabolic pathways. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK) and may alter the expression of metabolic genes, potentially impacting ABHD14A levels. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
As a selective agonist for PPAR-alpha, WY-14643 regulates fatty acid metabolism and could indirectly influence ABHD14A expression. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
By activating PPAR-alpha, fenofibrate modulates fatty acid oxidation genes and may affect ABHD14A expression. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
An older PPAR-alpha agonist, clofibrate affects lipid metabolism and could potentially alter ABHD14A gene expression. | ||||||
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $49.00 $170.00 $267.00 $661.00 | 6 | |
A potent PPAR-alpha activator, GW7647 influences lipid metabolic pathways and could indirectly affect ABHD14A expression. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
An AMPK activator, AICAR modulates energy metabolism and might have an impact on ABHD14A expression. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
As a pan-PPAR activator, bezafibrate influences lipid and glucose metabolism, potentially affecting ABHD14A expression. | ||||||